Diabetologia

, Volume 37, Issue 11, pp 1088–1096 | Cite as

Beta-cell proliferation in normal and streptozotocin-treated newborn rats: site, dynamics and capacity

  • R. N. Wang
  • L. Bouwens
  • G. Klöppel
Originals

Summary

Regeneration of neonatal beta cells after streptozotocin (STZ)-induced destruction may be due to either replication from pre-existing intra-islet beta cells or extra-islet precursor cells. To further investigate this issue, beta-cell growth was analysed in normal and streptozotocin-treated newborn rats (100 μg/g body weight) at several time points during the first 20 days of life. Beta cells were identified by insulin immunostaining, non-isotopic in situ hybridization for rat preproinsulin mRNA, and electron microscopy. Their proliferative activity was recorded by bromodeoxyuridine-pulse labelling. Beta-cell size and total volume were determined by computerized morphometry. In normal rats, there was a threefold increase in total beta-cell volume during the first 5 days of life, with no further expansion till day 20. The bromodeoxyuridine labelling index of the intraislet beta cells was smaller than that of the extra-islet beta cells (2–3% vs 15–20%). Comparison of the cell birth rate, calculated from the beta-cell labelling index, with the observed increase in beta-cell volume suggested that in normal neonatal rats proliferation of the intra-islet beta-cell population could account for only 10% of the observed expansion. Administration of streptozotocin at birth resulted in more than 90% reduction of the total beta-cell volume at day 2, which then increased to 39% of the normal value by day 20. During this period of partial regeneration, which restored normoglycaemia, the labelling index of intra-islet beta cells was higher than in normal rats (9% vs 2%, p<0.001), whereas no change was seen in the extra-islet beta-cell labelling index. Comparison of cell birth rate with the increase in beta-cell volume indicated that 50–60% of the observed beta-cell growth could result from the intra-islet beta-cell proliferation. These results suggest that replication from pre-existing, surviving beta cells plays an important role in regeneration of neonatal beta cells after destruction by streptozotocin.

Key words

Streptozotocin diabetes neonatal rat beta-cell proliferation immunocytochemistry morphometry 

Abbreviations

STZ

Streptozotocin

BrdU

bromodeoxyuridine

DIG

digoxigenin

SSC

sodium chloride, sodium citrate

LI

labelling index

References

  1. 1.
    Swenne I (1992) Pancreatic beta-cell growth and diabetes mellitus. Diabetologia 35: 192–201Google Scholar
  2. 2.
    Vinik AI (1992) Pancreatic islet cell regeneration and growth: introduction. Adv Exp Med Biol 321: 1–5Google Scholar
  3. 3.
    Welsh M, Mares J, Öberg C, Karlsson T (1993) Genetic factors of importance for β-cell proliferation. Diabetes/Metabolism Reviews 9: 25–36Google Scholar
  4. 4.
    Swenne I (1982) The role of glucose in the vitro regulation of cell cycle kinetics and proliferation of fetal pancreatic β-cells. Diabetes 31: 745–760Google Scholar
  5. 5.
    Hellerström C, Swenne I (1991) Functional maturation and proliferation of fetal pancreatic β-cells. Diabetes 40 [Suppl 2]: 89–93Google Scholar
  6. 6.
    Rutter WJ (1980) The development of the endocrine and exocrine pancreas. In: Fitzgerald PJ, Morrison AB (eds) The pancreas, chapter 2, Williams and Wilkins, Baltimore pp 30–38Google Scholar
  7. 7.
    Dubois PM (1989) Ontogeny of the endocrine pancreas. Horm Res 32: 53–60Google Scholar
  8. 8.
    Fuji S (1979) Development of pancreatic endocrine cell in the rat fetus. Arch Histol Jpn 42: 467–479Google Scholar
  9. 9.
    Yoshinari M, Daikoku S (1982) Ontogenic appearance of immunoreactive endocrine cell in rat pancreatic islets. Anat Embryol 165: 63–70Google Scholar
  10. 10.
    Logothetopoulos J (1972) Islet cell regeneration and neogenesis. In: Steiner DF and Freinkel N (eds) Handbook of physiology, sect. 7 Endocrinology Vol.1 American Physiological Society, pp 67–76Google Scholar
  11. 11.
    Hellerström C (1984) The life story of the pancreatic β cell. Diabetologia 26: 393–400Google Scholar
  12. 12.
    Cantenys D, Portha B, Dutrillaux MC, Hollande E, Rozé C, Picon L (1981) Histogenesis of the endocrine pancreas in newborn rats after destruction by streptozotocin. Virchows Arch B (Cell Pathol) 35: 109–122Google Scholar
  13. 13.
    Dutrillaux MC, Portha B, Rozé C, Hollande E (1982) Ultrastructural study of pancreatic β cell regeneration in newborn rats after destruction by streptozotocin. Virchows Arch B (Cell Pathol) 39: 173–185Google Scholar
  14. 14.
    Bonner-Weir S, Trent DF, Honey RN, Weir GC (1981) Responses of neonatal rat islets to streptozotocin. Diabetes 30: 64–69Google Scholar
  15. 15.
    Bonner-Weir S, Trent DF, Zmachinski CJ, Clore ET, Weir GC (1981) Limited B cell regeneration in a B cell deficient rat model: studies with dexamethasone. Metabolism 30: 914–918Google Scholar
  16. 16.
    Weir GC, Leahy JL, Bonner-Weir S (1986) Experimental reduction of β-cell mass: implications for the pathogenesis of diabetes. Diabetes/Metabolism Review 21: 125–161Google Scholar
  17. 17.
    Portha B, Levacher C, Picon L, Rosselin G (1974) Diabetogenic effect of streptozotocin in the rat during the perinatal period. Diabetes 23: 889–895Google Scholar
  18. 18.
    Soriano E, Del Rio JA (1991) Simultaneous immunocytochemical visualization of BrdU and neural tissue antigens. J Histochem Cytochem 39: 255–263Google Scholar
  19. 19.
    Aherne WA, Dunnill MS (1982) The estimation of whole organ volume. In: Aherne WA, Dunnill MS (eds) Morphometry, chapter 2, Edward Arnold Ltd., London, pp10–18Google Scholar
  20. 20.
    Komminoth P (1992) Digoxigenin as an alterative probe labelling for in situ hybridization. Diagn Mol Pathol 1: 142–150Google Scholar
  21. 21.
    Williams MA (1985) Stereological techniques. In: Williams MA (ed), Quantitative methods in biology, chapter 2, North-Holland Ltd., Amsterdam, pp 5–84Google Scholar
  22. 22.
    Swenne I (1983) Effect of aging on the regenerative capacity of the pancreatic β-cells of the rat. Diabetes 32: 14–19Google Scholar
  23. 23.
    Aherne WA, Camplejohn RS, Wright NA (1977) An introduction to cell population kinetics. Edward Arnold, London, pp88Google Scholar
  24. 24.
    McEvoy RC, Madson KL (1980) Pancreatic insulin-, glucagon-, and somatostatin-positive islet cell populations during the perinatal development of the rat: I. Morphometric quantitation. Biol Neonate 38:248–254Google Scholar
  25. 25.
    McEvoy RC (1981) Changes in the volumes of the A-, B-, and D-cell populations in the pancreatic islets during the postnatal development of the rat. Diabetes 30:813–817Google Scholar
  26. 26.
    Van Gompel J, Mahler T, De Paepe M, Klöppel G (1993) Comparison of in situ hybridization and immunocytochemistry for the detection of residual beta-cells in the pancreas of streptozotocin-treated diabetic rats. Acta Diabetologica 30:118–122Google Scholar
  27. 27.
    Leduque P, Aratan-Spire S, Wolf B, Dubois PM, Czernichow P (1987) Localization of thyrotropin-releasing hormone- and insulin-immunoreactivity in the pancreas of neonatal rats after injection of streptozotocin at birth. Cell Tissue Res 248: 89–94Google Scholar
  28. 28.
    Hellerström C, Swenne I (1985) Growth of the pancreatic islets in animals. In: Volk BW, Arquilla ER (eds) The diabetic pancreas. 2nd edn. Plenum, New York, pp 53–79Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • R. N. Wang
    • 1
  • L. Bouwens
    • 1
  • G. Klöppel
    • 1
  1. 1.Department of Experimental PathologyFree University of BrusselsBrusselsBelgium

Personalised recommendations